LONDON, July 11, 2019 /PRNewswire/ — Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces the results of the first ever prospective clinical trial to evaluate the effectiveness of repairing Horizontal Cleavage Tears (HCTs), one of the most common meniscal tears affecting approximately one-third of patients with this injury.1 The STITCH Study is examining the …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone